Open AccessPost‐coital gross hematuria: an unusual presentation of benign prostatic hyperplasia
Author(s) -
Chen YiHong,
Lin PeiYu,
Cheng YuSheng,
Lin Johnny ShinnNan,
Lin YungMing
Publication year - 2007
Publication title -
asian journal of andrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.701
H-Index - 74
eISSN - 1745-7262
pISSN - 1008-682X
DOI - 10.1111/j.1745-7262.2007.00326.x
Subject(s) - fulguration , medicine , gross hematuria , dutasteride , lower urinary tract symptoms , urology , hyperplasia , 5 alpha reductase inhibitor , prostate , presentation (obstetrics) , gynecology , finasteride , surgery , cancer
Aim: To describe an unusual symptom of benign prostatic hyperplasia (BPH). Methods: A patient presented to our urology clinic having experienced post‐coital gross hematuria for 2 years. He had not experienced lower urinary tract symptoms (LUTS). A series of examinations were performed to determine the source of bleeding. Results: The prostate was defined as the active bleeding source responsible for the patient's post‐coital hematuria. Endoscopic fulguration did not alleviate the symptom. The use of dutasteride, a dual inhibitor of 5α‐reductase, solved the problem. Conclusion: This study reports for the first time that post‐coital gross hematuria is one of the clinical presentations of BPH, which can be successfully treated with 5α‐reductase inhibitor.